SGO Winter Meeting
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Related Articles
Updated safety and efficacy from a Phase 1 study of RMC-6236, a RAS(ON) multi-selective, tri-complex inhibitor, in patients with RAS mutant pancreatic ductal adenocarcinoma (PDAC)
Dr. Brian Wolpin discusses updated safety and efficacy results from the Phase 1 study of RMC-6236, a RAS(ON) multi-selective inhibitor, highlighting its promising activity, manageable…
Molecular Subtyping Predicts Recurrence and Survival Benefits in Endometrial Cancer
The addition of chemotherapy to radiation therapy following surgery conferred a benefit in certain endometrial cancer molecular subtypes.
The Grotzinger Lecture: A Revered Tradition at Fox Chase Cancer Center
Members of the Fox Chase Cancer Center community gathered on January 21, 2025 for the Paul J. Grotzinger, MD, Memorial Lecture.
Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer
An observational cohort study determined that discordance exists between p53 protein expression and TP53 mutation status in high-risk endometrial cancer.
Blood Podcast | Blood | American Society of Hematology
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly…
Fluorescent-Based Imaging with AI Can Improve Surgery in Breast and Ovarian Cancer
The FIBI technology, created by Farzad Fereidouni, PhD, when combined with AI eliminates the need for frozen sections and other labor-intensive oncology surgery practices.
Clinicians Agree With Some ChatGPT Responses to Patient Inquiries on Colon Cancer – Oncology Nurse Advisor
Researchers compared responses from ChatGPT on colon cancer with expert opinion from oncology clinicians.
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Revisit Every OncLive On Air Episode From January 2025
In case you missed any, read a recap of the episodes of OncLive On Air that aired in January 2025.
Evaluating the Risk of Second Primary Cancers After CAR T-Cell Therapy
The association of CAR T-cell therapies with second primary cancers warrants the development and examination of mitigation strategies for these toxic effects.
